scholarly journals Presentation of varicella zoster virus infection with bladder mass and gross hematuria

2021 ◽  
Vol 15 (6) ◽  
pp. 2035-2036
Author(s):  
Mosa Asadi ◽  
Mohammad Reza Fattahi
Keyword(s):  
Herpes Zoster ◽  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Immunosuppressive Drugs ◽  
Varicella Zoster Virus Infection ◽  
Virus Reactivation ◽  
Varicella Zoster ◽  
The United Kingdom ◽  
Immunodeficiency Virus ◽  
Bladder Mass

INTRODUCTION Varicella zoster virus reactivation can cause localized, painfull and vesicular rashes that usually involves unilateral neural dermatomes. The most important risk factors for the incidence of herpes zoster ,are immunosuppression and age increasing. some studies defined the incidence of herpes zoster as 3.4 cases per 1,000 persons per year in the United Kingdom (1). The epidemiology of herpes zoster is affected by host factors that lead to the reactivation of latent virus. The incidence of herpes zoster increases with advancing age. Most cases of herpes zoster occur in patients who are more than 45 years old. More than 10 cases of herpes zoster per 1,000 persons per year are diagnosed in 75 years (2). Herpes zoster is also more common in patients treated with immunosuppressive drugs, malignant diseases, human immunodeficiency virus infection or in patients with organ transplants .(3, 4, 5, 6,7).

High Incidence of Varicella Herpes Zoster with Use of Bortezomib in Chinese Patients.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 5114-5114
Author(s):  
Yin Tong ◽  
Jie Jing Qian ◽  
Ying Li ◽  
Hai Tao Meng ◽  
Jie Jin
Keyword(s):  
Multiple Myeloma ◽  
Herpes Zoster ◽  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Cell Lymphoma ◽  
Acute Myeloblastic Leukemia ◽  
Chinese Patients ◽  
Varicella Zoster Virus Infection ◽  
Varicella Zoster ◽  
High Incidence

Abstract Bortezomib has been used for patients with refractory and relapsed multiple myeloma, non-Hodgkin lymphoma and leukemia in recent years. It has several complications. Here we report the complication of varicella herpes zoster after using bortezomib, which has higher incidence in Chinese patients. Ten patients were treated with bortezomib in our hematology centre. Among them, seven patients had refractory and relapsed multiple myeloma, two patients had refractory lymphoma (one of T cell lymphoma and one of mantle cell lymphoma) and one patient had refractory acute myeloblastic leukemia. All the patients received bortezomib (1.3 mg/m2) on days 1, 4, 8, and 11 of a 3-week cycle. Patients of multiple myeloma received dexamethasone simultaneously. The combination with liposomal doxorubicin was used on the patients of lymphoma. The patient of acute myeloblastic leukemia received bortezomib in combination with Amsacrine. After one cycle, 6 patients with multiple myeloma responded to treatment (four near complete remission, two partly remission). Two patients with lymphoma reached PR. The patient with leukemia had no response. A remarkable observation in our treatment was the high incidence of varicella herpes zoster. Six out of ten patients developed varicella herpes zoster. Among the six patients, two patients had previous infection of the zoster virus before. Most of the patients had the varicella herpes zoster infection after the complete of one cycle of bortezomib and were disappeared within one month by the use of antiviral treatment. The incidence of varicella hepers zoster after bortezomib was around 13% as reported. But the higher incidence of varicella herpes zoster were observed in our patients. Six of ten patients (60%) developed varicella zoster virus infection during treatment. We considered that the Chinese patients may be more liable to varicella zoster virus infection. And further observations should be made in the future. Prophylactic antiviral medication might be used in predisposed patients who receive bortezomib.

scholarly journals Acute Urinary Retention Following Primary VaricellaZoster Virus Infection

2021 ◽  
Vol 2 (2) ◽  
pp. 59-61
Author(s):  
Kamran Hassan Bhatti
Keyword(s):  
Herpes Zoster ◽  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Urinary Retention ◽  
Acute Urinary Retention ◽  
Treatment Plan ◽  
Varicella Zoster Virus Infection ◽  
Lumbosacral Region ◽  
Varicella Zoster ◽  
Urological Symptoms

Background Acute urinary retention following primary varicella-zoster virus infection (chickenpox) is very rare. Case Presentation We present a case of 34 years old male patient presented with acute urinary retention following primary varicella-zoster virus infection (chickenpox), there was no lesion detected neither by MRI brain nor whole spinal cord imaging. There was a typical blistering rash over the face, trunk, back and upper limbs but sparing the perennial and perianal area. Conclusion Once herpes zoster is found in lumbar lumbosacral region be alert there is possibility of voiding dysfunction like acute retention of urine. The effective treatment plan includes antiviral therapy and urethral catheterization. Most of urological symptoms due to herpes zoster subsides in the very short duration with active guideline treatment. Keywords: Varicella-zoster virus infection; Blister-like rash; Acute urinary retention.

scholarly journals Prevention & Management of Herpes Zoster- an Update

2014 ◽  
Vol 41 (3) ◽  
pp. 53-56
Author(s):  
AKM Rejaul Haque ◽  
A Sultana ◽  
A Habib ◽  
ASM Zakaria
Keyword(s):  
Herpes Zoster ◽  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Age Factors ◽  
Varicella Vaccine ◽  
Varicella Zoster Virus Infection ◽  
Post Herpetic Neuralgia ◽  
Varicella Zoster ◽  
Burning Pain ◽  
Chronic Corticosteroid

Herpes zoster (commonly referred to as "shingles") results .from reactivation of the varicella-zoster virus infection, or chickenpox. Were as varicella is generally a disease of childhood, herpes zoster becomes more common with increasing age Factors that decrease immune function, such as human immunodeficiency virus infection, chemotherapv, malignancies and chronic corticosteroid use, may also increase the risk of developing herpes zoster. Reactivation of latent varicella-zoster virus from dorsal root ganglia is responsible.for lhe classic dermatomal rash and pain that occur with herpes zoster. Burning pain typically precedes the rash by several days and can persist for several months after the rash resolves. With post herpetic neuralgia, a complication of herpes zoster, pain may persist well after resolution of the rash and can be highly debilitating. Although the diagnosis of the conditions is generally straightforward, treatment can be frustrating for the patient and physician. Approaches to management include treatment of the herpes zoster infection and associated pain, prevention of post herpetic neuralgia, and control of the neuropathic pain until the condition resolves. Herpes zoster is contagious to those who have not had varicella or have not received the varicella vaccine. The role of the varicella vaccine in preventing herpes zoster is uncertain, but is being studied. The management of herpes zoster is challenging because many patients develop troublesome complication. So, appropriate management o/'herpes zoster is very important to avoid complication. On the other hand prevention is better than cure. Immunization with varicella zoster virus vaccine may boost humoral and cell mediated and decrease the incidence of zoster in population. So effectiveness of a vaccination program need to be evaluated. immunity DOI: http://dx.doi.org/10.3329/bmj.v41i3.18961 Bangladesh Medical Journal 2012 Vol.41(3): 53-56

scholarly journals Varicella Zoster Antibodies after Herpes Zoster, Varicella and Multiple Sclerosis

1997 ◽  
Vol 24 (2) ◽  
pp. 137-139 ◽  
Author(s):  
R.T. Ross ◽  
L.E. Nicolle ◽  
M.R. Dawood ◽  
Mary Cheang ◽  
C. Feschuk
Keyword(s):  
Herpes Zoster ◽  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Population Group ◽  
Population Based ◽  
Postal Code ◽  
Enzyme Linked Immunosorbent Assay ◽  
Varicella Zoster Virus Infection ◽  
Varicella Zoster ◽  
Physician Care

ABSTRACT:Background:We previously showed that Manitoba Hutterites seek physician care for varicella zoster virus infection significantly less than non-Hutterites. The current study was undertaken to measure varicella zoster virus seroprevalence for Hutterite and non-Hutterite controls.Methods:Blood was obtained from 315 Hutterites and 259 similar age and sex controls at the time of blood donations to The Canadian Red Cross Society. The controls were from the same or a contiguous postal code area and were collected at the same time as the Hutterite samples. The immune status of the specimens was determined by the ELISA method (enzyme linked immunosorbent assay).Results:Twenty-eight per cent of 315 Hutterites had no immunity and an additional 25% had only marginal immunity. Among the 259 controls, 10% had no immunity and an additional 10% had only marginal immunity (p < .0001).Conclusions:Manitoba Hutterites have significantly decreased seroprevalence to varicella zoster virus infection. This study of serum varicella zoster virus antibodies verifies a previous population based study that demonstrated the relative rarity of varicella and herpes zoster among a particular population group.

scholarly journals Epidemiology of varicella zoster virus infection in Canada and the United Kingdom – CORRIGENDUM

2014 ◽  
Vol 143 (6) ◽  
pp. 1332-1332 ◽  
Author(s):  
M. BRISSON ◽  
W. J. EDMUNDS ◽  
B. LAW ◽  
N. J. GAY ◽  
R. WALLD ◽  
...  
Keyword(s):  
United Kingdom ◽  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Varicella Zoster Virus Infection ◽  
Varicella Zoster ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document